carbamazepine has been researched along with Batten Turner Congenital Myopathy in 8 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both forms of myotonia congenita are attributable to mutations in the CLCN1 gene." | 1.36 | Novel CLCN1 mutation in carbamazepine-responsive myotonia congenita. ( Duron, R; Holden, KR; Lyons, MJ; Molinero, I; Sangiuolo, F, 2010) |
| "Myotonia congenita is a rare disease of skeletal muscle characterized by painless myotonia, generalized muscular hypertrophy and a non-progressive course." | 1.33 | Myotonia congenita--a successful response to carbamazepine. ( Hyderi, A; Krishnamurthy, B; Ramachandra, NB; Savitha, MR, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fuseya, Y | 1 |
| Ishikawa, N | 1 |
| Sasaki, R | 1 |
| Yamashita, H | 1 |
| Desaphy, JF | 1 |
| Carbonara, R | 1 |
| Costanza, T | 1 |
| Conte Camerino, D | 1 |
| Lyons, MJ | 1 |
| Duron, R | 1 |
| Molinero, I | 1 |
| Sangiuolo, F | 1 |
| Holden, KR | 1 |
| Savitha, MR | 1 |
| Krishnamurthy, B | 1 |
| Hyderi, A | 1 |
| Ramachandra, NB | 1 |
| Berardinelli, A | 1 |
| Gorni, K | 1 |
| Orcesi, S | 1 |
| Sheela, SR | 1 |
| Hahn, AF | 1 |
| Parkes, AW | 1 |
| Bolton, CF | 1 |
| Stewart, SA | 1 |
| Jusić, A | 1 |
| Stimac, D | 1 |
8 other studies available for carbamazepine and Batten Turner Congenital Myopathy
| Article | Year |
|---|---|
Teaching Video NeuroImage: Carbamazepine Improves Gait Initiation in Autosomal Recessive Myotonia Congenita.
Topics: Carbamazepine; Chloride Channels; Electromyography; Gait; Genes, Recessive; Humans; Myotonia Congeni | 2022 |
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Topics: Animals; Carbamazepine; Disease Models, Animal; Flecainide; HEK293 Cells; Humans; Mexiletine; Muscle | 2014 |
Novel CLCN1 mutation in carbamazepine-responsive myotonia congenita.
Topics: Adolescent; Carbamazepine; Chloride Channels; Genes, Recessive; Humans; Male; Mutation; Myotonia Con | 2010 |
Myotonia congenita--a successful response to carbamazepine.
Topics: Carbamazepine; Child; Female; Humans; Myotonia Congenita; Neuromuscular Agents; Treatment Outcome | 2006 |
Response to carbamazepine of recessive-type myotonia congenita.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Humans; Male; Myotonia Congenita | 2000 |
Myotonia congenita: response to carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child, Preschool; Female; Humans; Male; Myotonia Congeni | 2000 |
Neuromyotonia in hereditary motor neuropathy.
Topics: Adolescent; Anti-Arrhythmia Agents; Carbamazepine; Child; Electromyography; Female; Humans; Lidocain | 1991 |
[Central genesis of dystrophia myotonica and Tegretal therapy].
Topics: Adult; Carbamazepine; Central Nervous System Diseases; Electromyography; Electrophysiology; Female; | 1972 |